Jump to content

Novo Nordisk Foundation

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by GoingBatty (talk | contribs) at 01:21, 28 November 2016 (clean up, typo(s) fixed: a international → an international using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The Novo Nordisk Foundation is an international foundation focusing on medical treatment and research. The foundation is the primary owner of Novo Nordisk A/S and NovoZymes A/S through its subsidiary company called Novo A/S.[1] The Foundation hands out more than 300 million US dollars each year to research within the fields of Life- and Bioscience.[2]

References

  1. ^ "Inside View: Novo Nordisk Foundation". 4 November 2015. doi:10.1038/nj0470. {{cite journal}}: Cite journal requires |journal= (help)
  2. ^ "Novo-fond fordobler støtte til forskning og gode formål".


Stub icon

This article about a medical organization or association is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Novo_Nordisk_Foundation&oldid=751824352"